Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...

Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer ...

There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.

Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...

Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...

NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.

The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...

Novocure stock soars 49% as the late-stage study of TTFields therapy for treating pancreatic adenocarcinoma meets the primary ...

Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...

Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...

In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose ...

StudyFinds' Dr. Faith Coleman speaks with the doctor testing a new vitamin C treatment that may double the survival time of ...